X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1082) 1082
Publication (71) 71
Newsletter (35) 35
Book Review (29) 29
Book Chapter (26) 26
Book / eBook (2) 2
Newspaper Article (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (864) 864
thrombotic thrombocytopenic purpura (546) 546
index medicus (483) 483
hematology (400) 400
female (379) 379
male (304) 304
thrombocytopenic purpura (265) 265
adult (250) 250
hemolytic-uremic syndrome (198) 198
middle aged (195) 195
factor-cleaving protease (159) 159
risk factors (141) 141
plasma exchange (127) 127
aged (126) 126
purpura, thrombotic thrombocytopenic - therapy (125) 125
treatment outcome (125) 125
von-willebrand-factor (119) 119
adamts13 protein (108) 108
purpura (108) 108
animals (105) 105
child (105) 105
thrombocytopenia (105) 105
adolescent (102) 102
pregnancy (101) 101
von willebrand factor (100) 100
medicine & public health (99) 99
thrombotic microangiopathy (96) 96
peripheral vascular disease (94) 94
plasma-exchange (93) 93
thrombosis (93) 93
care and treatment (89) 89
rituximab (89) 89
diagnosis (88) 88
adamts13 (86) 86
medicine, general & internal (84) 84
urology & nephrology (84) 84
health aspects (83) 83
management (78) 78
purpura, thrombotic thrombocytopenic - diagnosis (76) 76
recurrence (76) 76
therapy (74) 74
prevention (71) 71
research (70) 70
plasma (69) 69
hemolytic uremic syndrome (68) 68
pediatrics (67) 67
retrospective studies (67) 67
transplantation (64) 64
platelet count (63) 63
child, preschool (62) 62
oncology (60) 60
splenectomy (60) 60
antibodies (59) 59
immunology (58) 58
platelet aggregation inhibitors - therapeutic use (57) 57
prognosis (56) 56
purpura, thrombotic thrombocytopenic - drug therapy (55) 55
hemic and lymphatic diseases (53) 53
pharmacology & pharmacy (53) 53
purpura, thrombotic thrombocytopenic - etiology (53) 53
idiopathic thrombocytopenic purpura (52) 52
children (51) 51
surgery (51) 51
disease (50) 50
plasmapheresis (50) 50
abridged index medicus (49) 49
diagnosis, differential (49) 49
platelet aggregation inhibitors - adverse effects (48) 48
platelets (47) 47
clopidogrel (45) 45
anemia (44) 44
purpura, thrombotic thrombocytopenic - blood (44) 44
ttp (44) 44
von willebrand factor - metabolism (44) 44
aspirin (43) 43
risk-factors (43) 43
ticlopidine - analogs & derivatives (43) 43
microangiopathy (42) 42
purpura, thrombotic thrombocytopenic - chemically induced (42) 42
ticlopidine (42) 42
young adult (42) 42
analysis (41) 41
cardiac & cardiovascular systems (41) 41
hemolytic-uremic syndrome - therapy (40) 40
patients (40) 40
purpura, thrombotic thrombocytopenic - prevention & control (40) 40
ticlopidine - adverse effects (40) 40
time factors (40) 40
mice (39) 39
thrombosis - prevention & control (39) 39
anticoagulants - therapeutic use (38) 38
aged, 80 and over (37) 37
blood platelets (37) 37
incidence (37) 37
medical research (37) 37
nephrology (37) 37
infant (36) 36
secondary prevention (36) 36
mortality (35) 35
ticlopidine - therapeutic use (35) 35
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1111) 1111
French (16) 16
German (9) 9
Japanese (2) 2
Polish (2) 2
Arabic (1) 1
Chinese (1) 1
Czech (1) 1
Dutch (1) 1
Korean (1) 1
Slovenian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 01/2013, Volume 121, Issue 1, pp. 38 - 47
A mild thrombocytopenia is relatively frequent during pregnancy and has generally no consequences for either the mother or the fetus. Although representing no... 
POSTPARTUM PLASMA-EXCHANGE | PLATELET COUNTS | VON-WILLEBRAND-DISEASE | IMMUNE THROMBOCYTOPENIA | OBSTETRIC PATIENTS | PURPURA | ACUTE FATTY LIVER | HELLP HEMOLYSIS | ELEVATED LIVER-ENZYMES | HEMATOLOGY | FACTOR-CLEAVING PROTEASE | HELLP Syndrome - drug therapy | Recurrence | Humans | Immunosuppressive Agents - therapeutic use | Hemolytic-Uremic Syndrome - blood | Plasma Exchange | Pregnancy Complications, Hematologic - drug therapy | Contraindications | Purpura, Thrombocytopenic, Idiopathic - blood | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Young Adult | Purpura, Thrombocytopenic, Idiopathic - therapy | HELLP Syndrome - diagnosis | Thrombocytopenia - drug therapy | Purpura, Thrombotic Thrombocytopenic - drug therapy | Adult | Female | Hemolytic-Uremic Syndrome - therapy | Hemolytic-Uremic Syndrome - diagnosis | Infant, Newborn | Diagnosis, Differential | Antibodies, Monoclonal, Murine-Derived | Thrombocytopenia - etiology | HELLP Syndrome - blood | Purpura, Thrombotic Thrombocytopenic - congenital | Thrombocytopenia - congenital | Rituximab | Anticoagulants - therapeutic use | Combined Modality Therapy | Purpura, Thrombotic Thrombocytopenic - diagnosis | Anticoagulants - adverse effects | Purpura, Thrombotic Thrombocytopenic - prevention & control | Danazol | Algorithms | Purpura, Thrombocytopenic, Idiopathic - diagnosis | Pre-Eclampsia - blood | Immunosuppressive Agents - adverse effects | Thrombocytopenia - diagnosis | Disease Management | Pregnancy - blood | Purpura, Thrombotic Thrombocytopenic - blood | Fetal Monitoring
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 01/2018, Volume 16, Issue 1, pp. 150 - 163
Essentials Obesity is a potential risk factor for development of thrombotic thrombocytopenic purpura (TTP). Obese ADAMTS‐13‐deficient mice were triggered with... 
macrophages | thrombotic thrombocytopenic purpura | mice | ADAMTS‐13 protein | obesity | ADAMTS-13 protein | SEVERE HEMOPHILIA-A | UNITED-STATES | FACTOR-VIII | CROSS-LINKING | FIBRIN-STABILIZING FACTOR | FACTOR-XIII DEFICIENCY | RECOMBINANT | COAGULATION | PERIPHERAL VASCULAR DISEASE | INHIBITORS | HEMATOLOGY | BLOOD | Clodronic Acid - pharmacology | Obesity - drug therapy | Male | Spleen - drug effects | Mice, 129 Strain | Obesity - blood | Purpura, Thrombotic Thrombocytopenic - etiology | Time Factors | Kupffer Cells - metabolism | von Willebrand Factor | Blood Platelets - drug effects | Disease Models, Animal | Phagocytosis - drug effects | Obesity - complications | Mice, Inbred C57BL | Cells, Cultured | Purpura, Thrombotic Thrombocytopenic - prevention & control | Kupffer Cells - drug effects | Mice, Knockout | Macrophages - metabolism | Animals | Spleen - metabolism | Blood Platelets - metabolism | ADAMTS13 Protein - genetics | ADAMTS13 Protein - deficiency | Macrophages - drug effects | Purpura, Thrombotic Thrombocytopenic - blood | Thrombocytopenic purpura | Obesity | Macrophages | Risk factors | Von Willebrand factor | Spleen | Thrombocytopenia | Liver | Injection | Bisphosphonates | L-Lactate dehydrogenase | Clodronic acid | Thrombotic thrombocytopenic purpura | Purpura | Liposomes | Lactic acid | Health risk assessment | Platelets | Phagocytosis
Journal Article
Journal Article
Journal Article
Blood, ISSN 0006-4971, 05/2015, Volume 125, Issue 21, pp. 3218 - 3219
In this issue of Blood, using a transgenic mouse model, Pickens et al describe that ectopic expression of ADAMTS13, exclusively in platelets, is able to... 
ARTERIAL THROMBOSIS | THROMBOTIC THROMBOCYTOPENIC PURPURA | HEMATOLOGY | PLATELETS | ADAM Proteins - metabolism | Animals | Thrombosis - complications | Purpura, Thrombotic Thrombocytopenic - prevention & control | Humans | Genetic Therapy - methods
Journal Article